fda announcement tirzepatide Today the issued its fastest approval for a novel drug (NME) since 2002, as part of the national priority voucher pilot program. ✔️ New option for chronic weight management ✔️ Full FDA reconsidering its decision to

PROMISING POTENTIAL GLP-1RAs offer a promising outlook as transformative therapies in glycemic control, weight management, neuroprotection, and cardiovascular and renal protection

Convenience is key when it comes to staying consistent with medical care, said Pikeville doctor, Dr

Now, generic drug manufacturers are challenging the granting of various Novo Nordisk patents at the European Patent Office, likely to clear the way for their own products

If you want a closer look at how soluble fiber fits into broader weight goals, read how fiber helps with weight management

Selective pharmacology helps

Trajectory of weight regain after cessation of GLP-1 receptor agonists: A systematic review and nonlinear meta-regression